Manulife Financial Corporation vs Nuwellis Inc — how do they compare? Manulife Financial Corporation trades at $42.82 (market cap $69.96B), while Nuwellis Inc trades at $2.84 (market cap $1.09M). The key difference: Manulife Financial Corporation is far larger — about 64183.5× Nuwellis Inc's market cap, and Manulife Financial Corporation pays a 3.14% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| MFC | NUWE | |
|---|---|---|
Market Cap | $69.96B | $1.09M |
Sector | Financials | Technology |
52-Week High | $43.39 | $527.46 |
52-Week Low | $29.90 | $2.80 |
Enterprise Value | $66.52B | -$722.58K |
Dividend Yield | 3.14% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NUWE trades at $3.00, up 5.26% today, following a 35:1 reverse stock split effective June 26, 2026. The company shows a low P/E of 0.06 and P/S of 0.01, but fundamentals are weak with a -217.22% net income margin and negative ROE. Recent news highlights patent awards and pediatric market expansion, yet cash flow remains negative. Analyst coverage is limited with a split buy/hold consensus.
Outlook is speculative; growth depends on successful commercialization of Aquadex therapy and cost management. Key risks include persistent losses, high cash burn, and competitive pressures. Investors should weigh low valuation against execution risks in the medical technology sector.
Trailing returns across standard periods
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →